Based in Toronto, Actium Capital Advisors is a venture capital company with a fund that invests in and assists, promising early- to mid-stage biopharmaceutical companies with leading edge medical technologies.

Our Partners have an extensive network and successful track record of operating, commercializing and ultimately selling early stage bioscience companies or taking them public. We deploy this considerable expertise to identify the most promising companies and to assist them in achieving successful outcomes for entrepreneurs, investors, and most importantly, patients in need of new and effective therapies. We are passionately committed to helping our portfolio companies succeed in this challenging industry.

If you would like more information on Actium and our fund, please contact us.